Nexam Chemical Holding AB (publ) Interim Financial Report 1 January – 30 June 2015
Increased activity at customers
The second quarter at a glance
Increased number of full scale production tests at customers within prioritized focus areas.
The subsidiary Nexam St Andrews Ltd receives an order of approximately SEK 2.4 million from a global pharmaceutical company.
The ongoing cost saving program is beginning to show results in the company’s cash flow.
Management and key persons in the company has subscribed for a total of 646,000 warrants.
Net sales for the second quarter totaled SEK 619,000 (385,000) and for the first six months SEK 1,132,000 (505,000). Profit/loss before tax for the second quarter amounted to SEK -5,578,000 (-9,099,000).
In comparison with the beginning of the year, the total assets at the end of the period amounted to SEK 68,565,000 (84,973,000), with cash and cash equivalents accounting for SEK 44,931,000 (62,543,000).
Cash flow from operating activities for the second quarter was SEK -6,737,000 (-10,649,000).
Lund 20 August, 2015
Board of Directors
These financial statements have not been audited by the Company´s auditor.
For further information concerning the report, please contact:
Anders Spetz, CEO
Tel: +46-(0)703 47 97 00
Lennart Holm, Chairman of the Board
Tel: +46-(0)706 30 85 62